Scientific Computing World is hosting a virtual roundtable (limited to 6-8 participants) in February (date tbc) for research leaders, scientists and R&D experts in drug discovery, particularly those working with new modalities, such as RNA therapeutics, gene therapies, ADCs (Antibody Drug Conjugates) and protein degraders.

With these new multiple modalities, existing software solutions may not be fit for purpose, so the discussion will explore how research teams are adapting to this changing landscape and what challenges and considerations they face.